Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the H1N1 Vaccine Sector?

The market for the H1N1 vaccine has been thriving and expanding robustly over the recent years. It is predicted to intensify from a value of $3.33 billion in 2024 to one of $3.52 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this increase during the historic period include prior influenza outbreaks, worldwide health security worry, the successful development and approval of vaccines, international vaccine drives, initiatives to educate the public about health, government subsidies and funding, along with the pharmaceutical industry’s adaptability.

In the coming years, the H1N1 vaccine market is projected to observe considerable growth, eventually increasing to a market size of $4.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. This projected increment in the forecasted period can be credited to extensive research on comprehensive vaccines, international vaccine fairness programs, the fortification of public health resilience, the strengthening of global health governance, and the integration of H1N1 vaccination within routine immunization practices. Key trends within this forecasted period comprise global readiness for pandemics, flu vaccination schemes, advancements in vaccine development, research on cross-protection, global health drives, technological enhancements in vaccine production, expansion of production capacities, and data observation and surveillance.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp

What Forces Are Driving The Growth Of The H1N1 Vaccine Market?

The escalation in outlay for research and development pursuits in immunology and vaccine science is anticipated to fuel the progress of the H1N1 vaccine market in the future. Vaccines serving the realm of immunology are crucial in thwarting infections and stimulating the production of antibodies to combat these infections. The study of immunology, a vital part of medical and biological sciences, is centered on comprehending the workings of the immune system. The H1N1 vaccine is a critical solution designed to enhance the production of antibodies, thereby providing immunity against a multitude of diseases. For example, in March 2023, as reported by the US-based National Institutes of Health (NIH), the swift creation of mRNA COVID-19 vaccines was facilitated by research backed by the NIH. By March 2022, over 577 million doses had been rolled out in the United States, potentially saving an estimated 2.4 million lives and averting 17 million hospitalizations. Consequently, the upswing in expenditure for research and development activities within immunology and vaccines is contributing heavily to the growth of the H1N1 vaccine market.

How Is The H1N1 Vaccine Industry Segmented Across Key Parameters?

The h1n1 vaccine market covered in this report is segmented –

1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine

2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination

3) By End Users: Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Inactivated Vaccine: Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine

2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine

What Notable Trends Are Shaping The Direction Of The H1N1 Vaccine Market?

Partnerships between corporations are becoming a significant trend, and their popularity is on the rise in the H1N1 (swine flu) vaccination market. Firms in the H1N1 (swine flu) vaccination industry are prioritizing these partnerships to increase their market presence. For example, in August 2022, a major pharmaceutical corporation and the Open Orphan subsidiary hVIVO reached a $123 million agreement to develop a new strain of the H1N1 influenza challenge virus. This deal has bolstered the growth opportunities for both companies within the sector.

Which Companies Currently Dominate The Competitive Landscape In The H1N1 Vaccine Industry?

Major companies operating in the H1N1 vaccine market are Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Which Geographic Regions Are Driving Demand In The H1N1 Vaccine Market?

North America was the largest region in the H1N1 vaccine market in 2024. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7881&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model